KLK3 and neoplasm: The PCWG3 also underlined that bone scan and PSA changes do not always accurately represent objective changes in tumor burden, highlighting the difficulty in identifying if the detection of new sites of disease on a follow-up bone scan represents flare of a pre-existing subclinical metastatic lesions or a true transition to a metastatic state.30